Table 4 The predictive value of five prognostic models for POD24.

From: Progression of disease within 24 months (POD24) in multiple myeloma implicates poor prognosis and limitations of current prediction models for POD24

 

Sensibility (%)

Specificity (%)

Accuracy (%)

Positive predictive value (%)

Positive predictive value (%)

AUC

mSMART3.0

81.2

33.7

47.5

33.3

81.4

0.574

ISS

42.0

55.6

51.7

27.9

70.1

0.488

R-ISS

27.5

75.7

61.8

31.7

71.9

0.516

R2-ISS

69.6

40.2

48.7

32.2

76.4

0.549

MASS

53.6

58.6

57.1

34.6

75.6

0.561

Back to article page